About the partnership
BlinkLab, a leading digital healthcare company focused on AI-powered diagnostics, is pleased to announce that it has engaged The Southwest Autism Research & Resource Center (SARRC) as a new clinical site for the main study phase of BlinkLab Dx 1’s ongoing FDA 510(k) diagnostic trial.
SARRC has been selected as it is a nationally recognised leader in the autism space with nearly three decades of operation and a strong track record of clinical services, pioneering research, and providing inclusive community support. SARRC provides a robust platform for research and collaboration with its dedicated research facilities, multidisciplinary clinician teams, and community connections. This main phase of the registrational trial will see an additional 750 to 900 participants enrolled, now that the early 100-participant phase of the study is nearing completion.
Dr Christopher J. Smith, Chief Science Officer at SARRC, commented:
"At SARRC we are committed to improving early detection of autism and efficient access to diagnostic evaluations for all families. To that end, we support out-of-the-box thinking about the use of technology to help expedite and make objective results easily obtainable, so more children can get into treatment sooner."
Commenting on the partnership with SARRC, Co-founder and CEO, Dr Henk-Jan Boele, stated:
“We are thrilled to collaborate with the SARRC—an esteemed institution in the US with extensive experience in conducting clinical trials and efficiently recruiting children at high volumes. We feel privileged to work alongside such a capable team! I'm pleased that my team made the strategic decision to implement a pilot phase ahead of the main study. This proactive step proved invaluable in optimizing recruitment workflows and refining standard operating procedures for clinicians, ultimately laying the groundwork for a more cost-effective and labor efficient main study."
BlinkLab’s Chairman, Mr Brian Leedman, also commented:
“Shortly we will commence data analysis on the first 100 patients in the initial pilot phase of this registrational study. The rate at which BlinkLab has reached this pivotal milestone has been quicker than anticipated, primarily due to a rapid rate of recruitment alongside a demonstrated enthusiasm from participating families.”
About SARRC
The Southwest Autism Research & Resource Center (SARRC) is a non-profit organisation based in Phoenix, Arizona dedicated to advancing research into individuals living with autism, as well as providing ongoing support to them and their families. SARRC has a robust diagnostic services program. Their expertise in diagnostic assessments is recognized around the US, and because of their expertise, they pride themselves on an efficient and accurate diagnostic model that other sites have tried to emulate.
SARRC conducts cutting-edge research aimed at ways to improve outcomes for individuals living with autism and their families, as well as examining effective interventions and improvements to best practice in the neurodivergence space.
The center also offers services like diagnostic evaluations, early intervention strategies, hosting educational programs and providing resources, vocational training programs, and support programs for individuals living with autism across all stages of life.
